MedPath

Predictive factor analysis for treatment of Ulcerative Colitis with Tofacitinib

Not Applicable
Conditions
lcerative Colitis
Registration Number
JPRN-UMIN000035011
Lead Sponsor
agasaki University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients with severe liver and kidney dysfunction 2. Patients with a history of drug hypersensitivity such as allergy to the ingredients of this drug 3. Pregnant women and patients who may be pregnant or breast-feeding 4. Other patients who have been judged inappropriate as research subjects by research managers (including colorectal biopsy cases)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath